Single-Use Bioprocessing Market is anticipated to touch USD 30,250 million by 2028, exhibiting a 20.5% CAGR during the forecast period (2021-2028), owing to the growing demand for pharmaceutical products.

To have an edge over the competition by knowing the market dynamics and current trends of “Single-Use Bioprocessing Market”, request for Sample Report here

Key Drivers and Emerging Trends

The growing application of single-use bioprocessing products by pharmaceutical producers and life science research organizations to increase productivity and minimize risk of cross-contamination, is one of the major factors fueling the single-use bioprocessing market. Additionally, the ongoing technological advancements, which include the adoption of big data, automation, and machine learning (ML) solutions in bioprocessing, for projecting errors and improve accuracy during medical procedures are projected to supplement the market growth. Other factors, which include ongoing developments in the healthcare industry and increasing research and development (R&D) activities, are projected to drive the market further. The growing demand from the biopharmaceutical industry and the emerging need for biopharmaceuticals to decrease initial investments will further expand the market growth. The speed and flexibility of single use bioprocessing technologies makes them suitable for manufacturing industry, thereby, fuelling the market size. However, concerns like extractability regarding disposable component which include plastic bags and environment concerns with high regular recurring expenses are likely to restrain the Single-Use Bioprocessing Market size.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Product – Segment Analysis

Simple & Peripheral Elements segment is estimated to expand at a faster CAGR over the forecast period owing to rising adoption of single-use bags incorporated with automation, tubing, filters, connectors, and transfer systems. As per the Single-Use Bioprocessing Market report, the inclination towards single use transfer lines over fixed piping networks, owing to the advancement in single-use system, will further strengthen the segment’s growth

End-use – Segment Analysis

Biopharmaceutical manufacturers segment is predicted to hold a substantial share over the upcoming years, owing to the low labor and material cost, reduction in the initial investment and research and development cost. Furthermore, the rising awareness, and prominence have augmented their adoption by several manufacturers, like CMOS, OEM, and the inhouse manufacturers, bolstering the segment’s growth.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Regional – Segment Analysis:

North America is estimated to witness a higher CAGR over the forecast period, primarily because of the increasing research and development expenditure, presence of well-developed healthcare infrastructure, and rising healthcare expenditure. The growing demand for biopharmaceuticals owing to the growing senior population is further projected to propel the regional growth.

However, Asia-Pacific single-use bioprocessing industry is projected to expand at a faster CAGR during the forecast period, owing to the expansion of pharma and laboratory market. The growing demand for bioprocess equipment, which include laboratory filtration systems and membrane-based microbial analysis will further contribute to the regional growth.

Top Market Players
Various notable players operating in the market, include, Sartorius AG, Danaher, Thermo Fisher Scientific Inc, Merck KGaA, Corning Incorporated, Pall Corporation, Eppendorf AG, Rentschler Biopharma SE, Meissner Filtration Products, Inc., OmniBRx Biotechnologies., among others.

Key Developments:

• • In 2021, Fujifilm Diosynth decided to invest USD 2 billion in its U.S. site on a large cell culture production. This site will include eight 20,000-liter bioreactors.
  • In 2020, Thermo Fisher Scientific launched the HyPerforma DynaDrive Single-Use Bioreactor (SUB) with enhanced scalability and performance. This product will support various large scale cell culture processes.
  • In 2020, the Biopharma business was acquired by Danaher from General Electric Company’s Life Sciences division. The business unit is now named as Cytiva and is a standalone operating company within Danaher’s Life Sciences segment.
  • In Sep 2020, Thermo Fisher Scientific has made an invested of more than USD 475 million on new capabilities at St. Louis site to expand its biologics development and manufacturing, cell and gene therapy and drug product development capabilities.
  • In March 2020, Danaher acquired the Biopharma business of General Electric Company’s Life Sciences division. The business will be called Cytiva and is a standalone operating company under the Danaher’s Life Sciences segment.

Segments covered in the Report:
The global Single-Use Bioprocessing Market has been segmented on the basis of Product, End-use, Workflow, and regions. Based on Product, the market is segmented into Apparatus & Plants, Simple & Peripheral Elements and Work Equipment. Based on End-use, the market is segmented into Biopharmaceutical Manufacturer, Academic & Clinical Research Institutes and Others. Based on Workflow, the market is segmented into Upstream, Fermentation and Downstream.

For detailed scope of the “Single-Use Bioprocessing Market” report request a Sample Copy of the report

Key questions answered in this research report:

• • At what pace is global Single-Use Bioprocessing Market growing? What will be the growth trend in the future?
  • What are the key drivers and restraints in Single-Use Bioprocessing Market? What will be the impact of drivers and restraints in the future?
  • What are the regional revenues and forecast breakdowns? Which are the major regional revenue pockets for growth in the global Single-Use Bioprocessing Market?
  • Which Product generated maximum revenues in 2020 and identify the most promising Product during the forecast period?
  • What are the various End-use of global Single-Use Bioprocessing Market and how they are poised to grow?
  • What companies are the major participants in this market and their business strategies, how does the competitive landscape look like?

Market Segmentation

Global Single-Use Bioprocessing Market by Product

• • Apparatus & Plants
  • Simple & Peripheral Elements
  • Work Equipment

Global Single-Use Bioprocessing Market by End-use

• • Biopharmaceutical Manufacturer
  • Academic & Clinical Research Institutes
  • Others

Global Single-Use Bioprocessing Market by Workflow

• • Upstream
  • Fermentation
  • Downstream

Global Single-Use Bioprocessing Market by Region

• • North America Single-Use Bioprocessing Market (Option 1: As a part of the free 25% customization)
    • By Product
    • By End-use
    • By Workflow
    • US Market All-Up
    • Canada Market All-Up
  • Europe Single-Use Bioprocessing Market (Option 2: As a part of the free 25% customization)
    • By Product
    • By End-use
    • By Workflow
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Single-Use Bioprocessing Market (Option 3: As a part of the free 25% customization)
    • By Product
    • By End-use
    • By Workflow
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Single-Use Bioprocessing Market (Option 4: As a part of the free 25% customization)
    • By Product
    • By End-use
    • By Workflow
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Major Players Operating in the Market Name (Option 5: As a part of the Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Sartorius AG
  • Danaher
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Corning Incorporated
  • Pall Corporation
  • Eppendorf AG
  • Rentschler Biopharma SE
  • Meissner Filtration Products, Inc.
  • OmniBRx Biotechnologies.